These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10913651)

  • 1. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty.
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcome of topical cyclosporine treatment following penetrating keratoplasty].
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Nippon Ganka Gakkai Zasshi; 1999 Apr; 103(4):306-10. PubMed ID: 10339976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine in pediatric keratoplasty.
    Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
    Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty.
    Inoue K; Kimura C; Amano S; Sato T; Fujita N; Kagaya F; Kaji Y; Tsuru T; Araie M
    Jpn J Ophthalmol; 2001; 45(4):378-82. PubMed ID: 11485770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.
    Sinha R; Jhanji V; Verma K; Sharma N; Biswas NR; Vajpayee RB
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1167-72. PubMed ID: 20414783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penetrating keratoplasty in high-risk children: prevention of graft rejection].
    Pleskova AV; Khvatova AV
    Vestn Oftalmol; 2014; 130(3):17-20. PubMed ID: 25098116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
    Javadi MA; Feizi S; Karbasian A; Rastegarpour A
    Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
    Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
    Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
    Mahlberg K; Uusitalo RJ; Oksala O
    Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.
    Yamazoe K; Yamazoe K; Yamaguchi T; Omoto M; Shimazaki J
    Cornea; 2014 Nov; 33(11):1157-63. PubMed ID: 25255133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
    Unal M; Yücel I
    Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
    Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
    Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The observation of tacrolimus eye drops preventing the early immunological rejection after penetrating keratoplasty for fungal keratitis].
    Xiang DM; Wang YX; Jia YN; Li SX; Zhai HL; Shi WY; Gao H
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):305-310. PubMed ID: 28412805
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
    Zhang W; Pan Z; Zhai C
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
    PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection.
    Marques RE; Leal I; Guerra PS; Barão RC; Quintas AM; Rodrigues W
    Eur J Ophthalmol; 2022 May; 32(3):1469-1481. PubMed ID: 34231398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.